Prognostic value of eight immune gene signatures in pancreatic cancer patients
Authors:
Open Access
- 5 February 2021
- journal article
- research article
- Published by Springer Nature in BMC Medical Genomics
- Vol. 14 (1) , 1-14
Abstract
Background: Pancreatic cancer is one of the most common malignant tumors of the digestive tract, and it has a poor prognosis. Traditional methods are not effective to accurately assess the prognosis of patients with pancreatic cancer. Immunotherapy is a new promising approach for the treatment of pancreatic cancer; however, some patients do not respond well to immunotherapy, which may be related to tumor microenvironment regulation. In this study, we use gene expression database to mine important immune genes and establish a prognostic prediction model for pancreatic cancer patients. We hope to provide a feasible method to evaluate the prognosis of pancreatic cancer and provide valuable targets for pancreatic cancer immunotherapy. Results: We used univariate COX proportional hazard regression analysis, the least absolute shrinkage and selection operator, and multivariate COX regression analysis to screen 8 genes related to prognosis from the 314 immune-related genes, and used them to construct a new clinical prediction model in the TCGA pancreatic cancer cohort. Subsequently, we evaluated the prognostic value of the model. The Kaplan–Meier cumulative curve showed that patients with low risk scores survived significantly longer than patients with high risk scores. The area under the ROC curve (AUC value) of the risk score was 0.755. The univariate COX analysis showed that the risk score was significantly related to overall survival (HR 1.406, 95% CI 1.237–1.598, P < 0.001), and multivariate analysis showed that the risk score was an independent prognostic factor (HR 1.400, 95% CI 1.287–1.522, P < 0.001). Correlation analysis found that immune genes are closely related to tumor immune microenvironment. Conclusions: Based on the TCGA-PAAD cohort, we identified immune-related markers with independent prognostic significance, validated, and analyzed their biological functions, to provide a feasible method for the prognosis of pancreatic cancer and provide potentially valuable targets for pancreatic cancer immunotherapy.Keywords
All Related Versions
Funding Information
- the National Science Foundation of China (81573451)
This publication has 47 references indexed in Scilit:
- Bioinformatic profiling identifies an immune-related risk signature for glioblastomaNeurology, 2016
- CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal AdenocarcinomaCancer Cell, 2016
- mTORC1 alters the expression of glycolytic genes by regulating KPNA2 abundancesJournal of Proteomics, 2016
- Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic CarcinomaCancer Immunology Research, 2015
- Pancreatic cancer: from state-of-the-art treatments to promising novel therapiesNature Reviews Clinical Oncology, 2015
- Prognostic Value of a Nine‐Gene Signature in Glioma Patients Based on mRNA Expression ProfilingCNS Neuroscience & Therapeutics, 2013
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human CancerImmunity, 2013
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Identification of liver metastasis-related genes in a novel human pancreatic carcinoma cell model by microarray analysisCancer Letters, 2009
- Effects of Positive End-Expiratory Pressure Breathing on Exercise-Induced Asthma*International Journal of Sports Medicine, 1981